A clinical trial has reportedly shown promising results in treating colon cancer, with patients remaining cancer-free for nearly three years. The treatment involves an experimental immunotherapy, although some reports also mention a new drug that could potentially change how one of the deadliest cancers is treated. It is unclear if the trial specifically focused on colon cancer or if the results also apply to other types of cancer, such as pancreatic cancer, which is mentioned in some reports.